Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/drp/volume-2016/1316326/figures/1316326.fig.003a.svgz" name="1316326.fig.003a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Patient 1</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/drp/volume-2016/1316326/figures/1316326.fig.003b.svgz" name="1316326.fig.003b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Patient 2</td></tr><tr class="fig-image" id="c"><td><object data="https://static.hindawi.com/articles/drp/volume-2016/1316326/figures/1316326.fig.003c.svgz" name="1316326.fig.003c" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(c) </b>Patient 3</td></tr><tr class="fig-image" id="d"><td><object data="https://static.hindawi.com/articles/drp/volume-2016/1316326/figures/1316326.fig.003d.svgz" name="1316326.fig.003d" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(d) </b>Patient 4</td></tr></table>

<div>Effect of Itolizumab on psoriasis patients after treatment.</div>

Dermatology Research and Practice

fig3

Figure 3

Figure 3: Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions 